Onena Medicines
PrivateLast Round
Series A
Oct 31, 2023
Total Funding Raised
$6.57M
Company Overview
Onena Medicines operates in Healthcare & Life Sciences and is based in Allschwil. Its latest recorded funding round was a Series A round in October 2023.
Onena Medicines is a biopharmaceutical company that utilizes an AI-centric platform for discovering and developing antibody-based medicines to treat recurrent and metastatic cancers and select rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Onena Medicines Comparables
Compare Onena Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BigHat Biosciences | 78% | |
| LabGenius Therapeutics | 76% | |
| Ymmunobio | 72% |
For institutional investors. Book with your work email.
Onena Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 31, 2023 | ||||
| Grant | Mar 1, 2023 | ||||
| Accelerator | Feb 1, 2022 | ||||
| Seed | Mar 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Onena Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avanteca Partners | Series A |
| DeepTek Gipuzkoa Fundazioa | Seed |
| BaseLaunch | Accelerator |
| Zurcher Kantonalbank | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 31, 2023
$4M round led by Zurcher Kantonalbank and Avanteca Partners
- Feb 1, 2022
$540K raised from BaseLaunch
For institutional investors. Book with your work email.
Onena Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Onena Medicines's valuation, stock price, and market status.
Is Onena Medicines a public or private company?
Onena Medicines is a private company.
What is the current stock price of Onena Medicines?
Onena Medicines is a private company, so its shares have no public market price. Caplight tracks Onena Medicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Onena Medicines worth (valuation)?
Valuation information for Onena Medicines is not publicly available.
Can I buy Onena Medicines stock?
Onena Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Onena Medicines's last funding round?
Onena Medicines's most recent funding round was Series A on October 31, 2023.
Who are the main investors in Onena Medicines?
Key investors in Onena Medicines include Avanteca Partners, Zurcher Kantonalbank.
Will Onena Medicines IPO soon?
No public IPO plans have been announced for Onena Medicines.
How can I track Onena Medicines secondary market activity?
Caplight tracks bids, offers, and trades in Onena Medicines's shares on secondary markets.